Related by context. All words. (Click for frequent words.) 70 tesmilifene 69 ixabepilone 69 tremelimumab 68 trastuzumab DM1 68 iniparib 68 Neuvenge 68 goserelin 68 Asentar 67 motesanib 67 mapatumumab 67 standard chemotherapy regimen 67 axitinib 67 phase IIb clinical 67 decitabine 67 Vitaxin 67 Jevtana 66 orBec 66 cediranib 66 Amrubicin 66 Vectibix 66 PSMA ADC 66 PROSTVAC TM 66 HGS ETR1 66 Allovectin 7 66 panitumumab 66 pertuzumab 66 enzastaurin 66 Xelox 66 GVAX immunotherapy 66 aflibercept 66 OncoVEX GM CSF 66 TNFerade 66 glufosfamide 66 T DM1 66 Advexin 65 ocrelizumab 65 Targretin 65 abiraterone acetate 65 sipuleucel T 65 IMC A# 65 alvespimycin 65 Dacogen injection 65 pegylated liposomal doxorubicin 65 BRAF inhibitor 65 Mylotarg 65 lumiliximab 65 vemurafenib 65 Viramidine 65 cangrelor 65 Bezielle 65 Ontak 65 dose cohort 65 daclizumab 65 cetuximab Erbitux 65 abiraterone 65 pomalidomide 65 Taxotere chemotherapy 65 galiximab 65 idraparinux 65 figitumumab 64 MAGE A3 ASCI 64 zalutumumab 64 FOLFOX4 64 docetaxel chemotherapy 64 ZACTIMA 64 Folfox 64 vandetanib 64 ImClone Erbitux 64 ASA# 64 PROCHYMAL 64 nonsmall cell lung cancer 64 Telcyta 64 Tarceva TM 64 Novartis Zometa 64 sunitinib 64 darapladib 64 BRIM2 64 rNAPc2 64 neratinib 64 afatinib 64 elotuzumab 64 elacytarabine 63 midstage trials 63 NATRECOR R 63 temsirolimus 63 ipilimumab 63 Allovectin 7 ® 63 Aflibercept 63 bevacizumab Avastin 63 Urocidin 63 MyVax 63 olaparib 63 dasatinib 63 Zybrestat 63 CoFactor 63 metastatic castration resistant 63 Dendreon Provenge 63 Ixempra 63 Ceflatonin 63 TroVax 63 HuMax CD# 63 EFAPROXYN 63 DAPT 63 Genasense 63 Erbitux cetuximab 63 Reverset 63 Theratope 63 Phase IIb clinical trials 63 valopicitabine 63 cabazitaxel 63 Phase Ib II 63 lixisenatide 63 FTY# 63 adecatumumab 63 tamoxifen therapy 63 BrachySil 63 rituximab Rituxan 63 dose cohorts 63 DEB# 63 nab paclitaxel 63 ToGA 63 PROMACTA 63 gemcitabine chemotherapy 63 lintuzumab 63 MDV# 63 MGd 63 ELACYT 63 teriflunomide 63 GRNVAC1 63 metastatic hormone refractory 63 rindopepimut 63 phase IIb trial 63 erlotinib Tarceva 63 mycophenolate mofetil 63 EndoTAG TM -1 63 adjuvant colon cancer 63 Panzem R NCD 63 patients evaluable 63 forodesine 63 BRIM3 63 Tarceva erlotinib 63 bevacizumab Avastin ® 63 bicifadine 63 midstage studies 63 SAR# [004] 63 Corlux 63 Folotyn 63 mg kg dose 63 postoperative chemotherapy 63 cilengitide 63 Pemetrexed 63 PLX# 63 RSR# 63 sorafenib Nexavar 62 Hycamtin 62 lapatinib Tykerb 62 Xinlay 62 Canvaxin 62 pegylated interferon alpha 62 TBC# 62 plus dexamethasone 62 bendamustine 62 midstage clinical trials 62 YONDELIS 62 cancer immunotherapies 62 Proxinium TM 62 CIMZIA TM 62 Velcade bortezomib 62 Fludara 62 Panitumumab 62 concurrent chemoradiation 62 FOLFOX chemotherapy 62 Vectibix panitumumab 62 Heplisav 62 riociguat 62 Temsirolimus 62 low dose cytarabine 62 midstage clinical 62 TORISEL 62 dacetuzumab 62 sunitinib Sutent 62 Phase 2a trial 62 Xyotax 62 tafamidis 62 Torisel 62 phase IIb 62 Removab 62 dose escalation phase 62 JAK inhibitor 62 ganetespib 62 mertansine 62 topotecan 62 refractory metastatic 62 Sutent sunitinib 62 Nexavar sorafenib 62 metastatic renal cell carcinoma 62 Aptivus ® 62 thymalfasin 62 Erbitux 62 oral ridaforolimus 62 custirsen 62 canakinumab 62 velafermin 62 EOquin TM 62 ularitide 62 TroVax ® 62 XGEVA 62 amrubicin 62 CD# antibody [001] 62 multicenter Phase II 62 Gleevec imatinib mesylate 62 PROSTVAC VF 62 clodronate 62 Specifid 62 DASISION 62 zoledronic acid 62 comparator arm 62 Virulizin ® 62 randomized Phase IIb 62 Vorapaxar 62 Tocosol Paclitaxel 62 recurrent glioblastoma multiforme 62 mCRC patients 62 PEG SN# 62 Taxotere docetaxel 62 edifoligide 62 aleglitazar 62 BCIRG 62 Taxotere ® 61 TELCYTA 61 Prochymal 61 CBLC# 61 recurrent GBM 61 SYMMETRY trial 61 CR# vcMMAE 61 ZOLINZA 61 CIMZIA ™ 61 Aplidin 61 bortezomib 61 Avastin 61 #I TM# 61 Cotara 61 letrozole 61 Gliadel Wafer 61 ATL# [001] 61 DCVax ® 61 SinuNase 61 HuMax EGFr 61 Ozarelix 61 Fulvestrant 61 ruxolitinib 61 liver metastases 61 Pfizer Sutent 61 Fablyn 61 vicriviroc 61 enoximone 61 recurrent metastatic 61 Tavocept 61 sunitinib malate 61 chemoradiotherapy 61 docetaxel Taxotere 61 subcutaneous PRO 61 GnRH agonists 61 Quinamed 61 fluvastatin 61 5-FU/LV 61 nilotinib 61 DU #b 61 PXD# 61 eniluracil 61 E2F Decoy 61 IMA# 61 mitoxantrone 61 gefitinib Iressa 61 clazosentan 61 bicalutamide 61 TELINTRA 61 carboplatin paclitaxel 61 pazopanib 61 Campath alemtuzumab 61 XELOX 61 HuMax CD4 61 hA# 61 Panzem 61 oblimersen 61 Degarelix 61 viral kinetic 61 biliary tract cancer 61 Traficet EN 61 Laquinimod 61 ACZ# 61 rhThrombin 61 relapsed MM 61 OHR/AVR# 61 PRT# 61 IMGN# 61 trastuzumab DM1 T DM1 61 active comparator 61 multiple myeloma MM 61 phase IIb study 61 PANVAC VF 61 taxotere 61 Tolamba 61 mRCC 61 Irinotecan 61 crizotinib PF # 61 OvaRex ® MAb 61 oral rivaroxaban 61 tanespimycin 61 visilizumab 61 ProSavin 61 Phase #b/#a 61 huC# DM4 61 phase Ib 61 Genentech Roche 61 talabostat 61 seliciclib 61 calcineurin inhibitor 61 dalbavancin 61 Taxotere 61 neoadjuvant chemotherapy 61 gemcitabine carboplatin 61 phase IIa clinical 61 HCV RESPOND 2 61 azacitidine 61 OncoVex 61 Alfimeprase 61 Vandetanib 61 antiangiogenic therapy 61 GRNCM1 61 AEGR 61 Syncria 61 OncoVEX 61 BAY #-# 61 iniparib BSI 61 XL# SAR# 61 BZL# 61 talactoferrin 61 Ipilimumab 61 Rituxan 61 Gleevec resistant 61 Herceptin trastuzumab 61 anastrozole 61 apremilast 61 Actilon 61 gefitinib 61 ZYBRESTAT 61 Azedra 61 Xcellerated T Cells 61 interferon gamma 1b 61 CYC# 61 VIDAZA 61 GVAX vaccine 61 dexanabinol 61 Rituxan rituximab 61 LibiGel Phase III 61 Dacogen 61 Motesanib 61 palonosetron 61 fondaparinux 61 Zactima 61 Sandostatin LAR Depot 61 HCV SPRINT 61 picoplatin 61 NV1FGF 61 Fusilev 61 Avastin bevacizumab 61 alkylating agent 61 systemic ALCL 61 tolevamer 61 XmAb# 61 Onconase 61 Provenge prostate cancer 61 Platinol 61 IIa trial 60 febuxostat 60 SCCHN 60 Zolinza 60 pegylated interferon alfa 2b 60 LHRH 60 romidepsin 60 Pegintron 60 Xcytrin 60 sorafenib 60 Telintra 60 Capesaris 60 octreotide 60 IMC #B 60 Phase IIa trial 60 dose escalation clinical 60 DCVax R Brain 60 cabozantinib 60 Revlimid 60 chemotherapeutic regimen 60 Reolysin 60 gadobutrol 60 PTK ZK 60 AEG# 60 SinuNase TM 60 milatuzumab 60 methylnaltrexone 60 adjuvant radiation 60 rFVIIa 60 DCVax Brain 60 Gleevec imatinib 60 Yervoy 60 Paraplatin 60 IRX 2 60 Treanda 60 prGCD 60 Targretin capsules 60 Insegia 60 Phase IIb trials 60 ancrod 60 APTIVUS 60 Troxatyl 60 hepatitis B vaccine Heplisav 60 Phase #/#a 60 mg/m2 dose 60 sapacitabine 60 eplerenone 60 deforolimus 60 antitumor effect 60 eltrombopag 60 ATACAND 60 paclitaxel Taxol ® 60 plus prednisone 60 MYDICAR 60 Alocrest 60 T#I [002] 60 vismodegib 60 Oncophage 60 CD3 monoclonal antibody 60 Ceplene/IL-2 60 liposomal formulation 60 riluzole 60 Campath 60 adefovir 60 Advagraf 60 Phase IIIb clinical 60 Arranon 60 NVA# 60 Doxil 60 Rituxan MabThera 60 anthracycline taxane 60 huN# DM1 60 metastatic renal cell 60 aldosterone antagonists 60 BrachySil TM 60 betrixaban 60 tipranavir 60 Phase 2b study 60 Dasatinib 60 GRN# 60 investigational monoclonal antibody 60 trastuzumab Herceptin 60 otamixaban 60 antibody MAb 60 TREANDA 60 oral clodronate 60 INCB# [001] 60 recurrent NSCLC 60 tofacitinib 60 relapsed multiple myeloma 60 Mipomersen 60 SUTENT 60 Vidaza azacitidine 60 OXi# 60 RSD# oral 60 intravenous cyclophosphamide 60 OPAXIO 60 oral deforolimus 60 farletuzumab 60 viral kinetics 60 Ziopharm 60 temozolomide 60 PrevOnco 60 NEVO ™ 60 HER2 positive metastatic breast 60 Navelbine ® 60 KRAS mutations occur 60 Aromasin 60 Pirfenidone 60 PROSTVAC ® 60 Merck KGaA Erbitux 60 squamous histology 60 Doxil ® 60 DXL# 60 denosumab 60 trastuzumab Herceptin R 60 ChronVac C R 60 Zarnestra 60 romiplostim 60 EOquin 60 peginterferon 60 CA4P 60 GAMMAGARD 60 prospectively defined 60 GALNS 60 ISEL 60 irbesartan 60 angiographic outcomes 60 Elitek 60 placebo dexamethasone 60 EGFR TKI 60 veltuzumab 60 infusional 5-FU/LV 60 tarenflurbil 60 Elotuzumab 60 ibandronate 60 Orathecin 60 DPX Survivac 60 T Pred 60 Neupogen ® 60 Lapatinib 60 sirolimus 60 Xanafide 60 Phase III randomized controlled 60 CYPHER Stent 60 rt PA 60 neurologic progression 60 Phase Ib clinical 60 FOLPI 60 NATRECOR ® 60 ELND# 60 Vernakalant 60 CIMZIA TM certolizumab pegol 60 Sprycel 60 regorafenib 59 GAP #B# 59 NEUVENGE 59 PrevOnco ™ 59 Genentech Rituxan 59 PARP inhibitor 59 letrozole Femara 59 Abraxane 59 Phase Ib study 59 docetaxel 59 metastatic kidney 59 metastatic castrate resistant 59 darusentan 59 evaluable patients 59 alpha interferon 59 Ocrelizumab 59 pharmacokinetic PK study 59 Cimzia TM 59 Betaferon ® 59 TNF alpha antagonist 59 Phase Ib 59 aflibercept VEGF Trap 59 metaglidasen 59 pediatric acute lymphoblastic 59 Femara letrozole 59 Bonefos 59 paclitaxel Taxol 59 complete cytogenetic response 59 docetaxel Taxotere ® 59 Fibrin Pad 59 Cethromycin 59 Cloretazine ® 59 MYDICAR ® 59 metastatic CRC 59 trastuzumab Herceptin ® 59 Amgen Vectibix 59 pemetrexed Alimta 59 Genentech Herceptin 59 ponatinib 59 MAXY G# 59 proteasome inhibitor 59 Prosaptide 59 Pivotal Phase III 59 tipranavir ritonavir 59 adalimumab 59 telaprevir VX 59 Alkeran 59 APTIVUS r 59 vidofludimus 59 AVOREN 59 Fibrillex 59 CINTREDEKIN BESUDOTOX 59 Phase #/#a trial 59 unresectable stage 59 rBChE 59 CVac 59 evaluable 59 oral diclofenac 59 Tarceva 59 Sym# 59 phase 2a 59 Topotecan 59 sorafenib tablets 59 PRADAXA 59 Tarvacin 59 Neovastat 59 LUX Lung 59 PEG INTRON 59 ThGRF 59 corticosteroid dexamethasone 59 tocilizumab 59 angiogenesis inhibitor 59 RE LY 59 Enzastaurin 59 Proleukin 59 OvaRex MAb 59 VEGF Trap 59 acyclovir Lauriad R 59 KRAS status 59 neoadjuvant 59 atrasentan 59 GW# [003] 59 Amigal 59 ONTAK 59 LCP Tacro 59 Phase IIB 59 alvimopan 59 recurrent GBM patients 59 NP2 Enkephalin 59 Crizotinib 59 flutamide 59 Pegylated Interferon 59 LY# [003] 59 Cabazitaxel 59 Acapodene 59 trastuzumab 59 pamidronate 59 chlorambucil 59 partial remissions 59 cobiprostone 59 dacarbazine chemotherapy 59 Glufosfamide 59 Gefitinib 59 anakinra 59 multicenter Phase 59 olmesartan 59 cilostazol 59 PEG interferon 59 Erlotinib 59 reslizumab 59 taspoglutide 59 Trastuzumab 59 imatinib therapy 59 Phase #b/#a clinical 59 SVR# 59 alteplase 59 obatoclax 59 Tykerb lapatinib 59 Dapagliflozin 59 APPRAISE 59 VIRAMUNE 59 simvastatin ezetimibe 59 AVADO 59 degarelix 59 lenalidomide Revlimid 59 Gemcitabine 59 SRT# [003] 59 remission CR 59 Aurexis 59 gemcitabine Gemzar 59 vinflunine 59 dutasteride 59 Insulin PH# 59 Technosphere Insulin 59 LAF# 59 Zalbin 59 Cinquil 59 Neulasta ® 59 RSD# 59 paricalcitol 59 AP# [003] 59 Abiraterone 59 heavily pretreated patients 59 GRN#L 59 L BLP# 59 Peg IFN 59 virologic failure 59 AVE# 59 entecavir 59 budesonide foam 59 stage IIIb IV 59 oral Xeloda 59 CHAMPION PCI 59 Recentin 59 K ras mutations 59 posaconazole 59 STRIDE PD 59 Oxaliplatin 59 docetaxel Taxotere R 59 HGS# 59 REOLYSIN ® 59 TACI Ig 59 estramustine 59 Xgeva 59 Abiraterone acetate 59 imatinib Gleevec 59 Archexin 59 Denosumab 59 Actemra 59 INGN 59 fosbretabulin 59 dirucotide 59 FOLFIRI 59 sustained virologic response 59 thalidomide Thalomid 59 MyVax R 59 Pertuzumab 59 OMAPRO 59 metastatic HRPC 59 QTc prolongation 59 subcutaneous formulation 59 Gemzar 59 Roche Xeloda 59 intermittent dosing 59 EVIZON 59 LEUKINE 59 Avastin adjuvant 59 Engerix B 59 Arimoclomol 59 NSABP C 59 taxane chemotherapy 59 StemEx 59 Byetta LAR 59 irinotecan chemotherapy 59 HCD# [002] 59 BioNumerik 59 refractory AML 59 belinostat 59 anidulafungin 59 Tykerb 59 Zometa zoledronic acid 59 peg interferon 59 methotrexate monotherapy 59 registrational trial 59 standard chemotherapy regimens 59 imatinib 59 IL# PE#QQR 59 FOLFOX 59 antiplatelet agent 59 otelixizumab 59 Viread Emtriva 59 locoregional recurrence 59 Gleevec Glivec 59 Revlimid lenalidomide 59 exemestane 59 Pazopanib 59 azilsartan medoxomil 59 CANCIDAS 59 differentiated thyroid 59 mcg dose 59 radiation sensitizer 59 monotherapy 59 TYKERB 59 Taxol paclitaxel 59 Octreolin 59 anti CD# antibodies 59 inhibitor RG# 59 Afatinib 59 adjuvant tamoxifen 58 Civacir 58 durable remissions 58 dimebon 58 BiovaxID 58 Phase IIa trials 58 HuLuc# 58 rituximab Rituxan ® 58 mTOR inhibitors 58 metastatic colorectal 58 Tamibarotene 58 prostate cancer CRPC 58 Promacta 58 cisplatin chemotherapy 58 AGGRASTAT R 58 Navelbine 58 TAXOTERE R 58 certolizumab 58 colorectal cancer liver metastases 58 tecarfarin 58 Alemtuzumab 58 adjuvant cisplatin 58 receptor tyrosine kinase inhibitor 58 Azacitidine 58 Factor VIIa 58 tipifarnib 58 eribulin 58 rilonacept 58 VNP#M 58 panitumumab Vectibix 58 CEQ# 58 peginterferon alfa 2b 58 protease inhibitor PI 58 Daclizumab 58 mTOR inhibitor 58 biologic therapy 58 TOCOSOL Paclitaxel 58 cetuximab Erbitux ® 58 Sanofi Aventis Taxotere 58 volociximab 58 calcitriol 58 FOLFIRINOX 58 cancer mCRC 58 LT NS# 58 TRISENOX 58 trastuzumab emtansine T DM1 58 ACTIVE W 58 lenalidomide dexamethasone 58 metastatic RCC 58 Raptiva ® 58 fulvestrant 58 Axitinib 58 Diamyd ® 58 celgosivir 58 aprepitant 58 RAD# [003] 58 HyQ 58 cancer neuroendocrine tumor 58 bevacizumab 58 Exherin TM 58 carfilzomib 58 Arixtra 58 nitazoxanide 58 REYATAZ R 58 Gabapentin GR 58 lomitapide 58 rosuvastatin #mg 58 FavId 58 NSABP 58 anti EGFR antibody 58 Clolar ® 58 squalamine 58 preoperative chemotherapy 58 AZILECT R 58 Taxus Liberte 58 fluorouracil 58 neoadjuvant therapy 58 alogliptin 58 INCB# [003] 58 relapsed ovarian cancer 58 mTOR inhibition 58 solanezumab 58 PF # [002] 58 azathioprine 58 MetMAb 58 bucindolol 58 dexpramipexole 58 glatiramer acetate 58 PRIMO CABG 58 ximelagatran 58 paclitaxel chemotherapy 58 lesinurad 58 gastrointestinal stromal tumors 58 Provecta 58 nonclinical studies 58 Vascugel ® 58 AQ4N 58 CYT# 58 FIRMAGON 58 Exelixis XL# 58 S/GSK# 58 urocortin 2 58 odanacatib 58 Genasense ® 58 Darusentan 58 bosutinib 58 dosing cohorts 58 Apoptone 58 luteinizing hormone releasing 58 OvaRex R 58 ozarelix 58 LPV r 58 gastrointestinal stromal tumors GIST 58 adalimumab Humira 58 UPLYSO 58 Vicinium TM 58 resected pancreatic cancer 58 DCVax R 58 Everolimus 58 YERVOY 58 Interferon alfa 58 Avastin Tarceva 58 thalidomide dexamethasone 58 Phase 1b 58 tramiprosate Alzhemed TM 58 octreotide acetate 58 Immunogen 58 ANCHOR trial 58 exenatide Byetta 58 IRESSA 58 nesiritide 58 Subgroup analysis 58 vorinostat 58 GeoVax vaccine 58 ERBITUX 58 refractory CLL 58 evaluating tivozanib 58 BEXXAR 58 Pralatrexate 58 dose escalation trial 58 paclitaxel cisplatin 58 plus gemcitabine 58 Pegasys plus Copegus 58 Cloretazine 58 Votrient 58 FOLFOX6 58 5 Fluorouracil 58 Glypromate 58 anti TNF alpha 58 CUSTOM III 58 Actimmune ® 58 AstraZeneca Iressa 58 pradefovir 58 Celgene Revlimid 58 Panzem NCD 58 preclinical efficacy 58 Viprinex 58 oral FTY# 58 Phase IIIb 58 brentuximab vedotin SGN 58 Exemestane 58 canagliflozin 58 dose escalation Phase 58 intravenous bisphosphonates 58 epoetin alfa 58 EDEMA3 58 AZOR 58 pegylated interferon alfa 58 Zadaxin 58 CLL SLL 58 clinical pharmacology studies 58 DCVax 58 lintuzumab SGN 58 CRp 58 Neuradiab 58 SCH # 58 blinded randomized placebo controlled 58 heavily pretreated 58 Nuvion 58 Ophena TM 58 nadolol 58 NLX P# 58 glargine 58 epratuzumab 58 Pimavanserin 58 Trastuzumab DM1 58 telaprevir dosed 58 Trovax 58 CellCept 58 tolvaptan 58 Saxagliptin 58 CHOP chemotherapy 58 oral prodrug 58 HGS ETR2 58 drug figitumumab 58 gp# vaccine 58 Zevalin consolidation 58 PSN# [002] 58 EndoTAGTM 1 58 pancreatic carcinoma 58 maribavir 58 preclinically 58 bardoxolone 58 insulin glargine 58 BeneFIX 58 double blinded placebo 58 Leukine 58 Onrigin 58 TNF antagonist 58 KRAS wild 58 ILLUMINATE 58 Tocosol 58 dacarbazine 58 Sapacitabine 58 rivaroxaban 58 evaluating REVLIMID 58 Virulizin R 58 gemcitabine Gemzar ® 58 Tanespimycin 58 clopidogrel Plavix 58 CTAP# Capsules 58 SparVax TM 58 adjuvant radiotherapy 58 pain palliation 58 randomized Phase 2b 58 Hycamtin ® 58 Epratuzumab 58 rituximab 58 imetelstat 58 nalbuphine ER 58 paclitaxel poliglumex 58 integrase inhibitor 58 registrational 58 telcagepant 58 BEACOPP 58 advanced carcinoid 58 MVax 58 argatroban 58 doxorubicin docetaxel 58 CMV disease 58 #D#C# 58 EGFR mutation 58 Hepatocellular Carcinoma HCC